Emergent BioSolutions Inc. Q2 2025 Earnings Conference Call
On August 6, 2025, Emergent BioSolutions Inc. (NYSE:EBS) hosted its Q2 2025 earnings conference call at 5:00 PM ET. Company executives, including CEO Joseph C. Papa and CFO Richard S. Lindahl, discussed financial and operational highlights for the quarter.
Open Access and Presentation Materials
The call was open to all participants and recorded for public access. Accompanying slides were available to webcast attendees, providing additional context. During the session, Emergent emphasized that certain forward-looking statements were made, based on current expectations and subject to risks outlined in their SEC filings. These projections involve assumptions that may change, and the company does not commit to updating them unless required.
Financial Measures and Strategic Updates
Additionally, the discussion included references to non-GAAP financial measures, aimed at offering clearer insights into operational performance, detailed further in the press release's accompanying tables.
Session Highlights
The agenda featured updates from CEO Joe Papa on the company's transforma...